Mountain Valley MD Holdings Inc
CNSX:MVMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mountain Valley MD Holdings Inc
Free Cash Flow
Mountain Valley MD Holdings Inc
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Mountain Valley MD Holdings Inc
CNSX:MVMD
|
Free Cash Flow
-CA$2.3m
|
CAGR 3-Years
21%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Wheaton Precious Metals Corp
TSX:WPM
|
Free Cash Flow
$563.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Barrick Gold Corp
TSX:ABX
|
Free Cash Flow
$3.9B
|
CAGR 3-Years
108%
|
CAGR 5-Years
3%
|
CAGR 10-Years
14%
|
|
|
Kinross Gold Corp
TSX:K
|
Free Cash Flow
$2.6B
|
CAGR 3-Years
108%
|
CAGR 5-Years
20%
|
CAGR 10-Years
28%
|
|
|
Franco-Nevada Corp
TSX:FNV
|
Free Cash Flow
-$703m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
0%
|
|
|
Agnico Eagle Mines Ltd
TSX:AEM
|
Free Cash Flow
$4.4B
|
CAGR 3-Years
99%
|
CAGR 5-Years
59%
|
CAGR 10-Years
39%
|
|
Mountain Valley MD Holdings Inc
Glance View
Mountain Valley MD Holdings, Inc. engages in the implementation of its patented Quicksome oral delivery technologies across molecules in nutraceutical, vaccine and pharmaceutical drug applications. The company is headquartered in Vaughan, Ontario. The company went IPO on 2018-03-02. Through its subsidiary, Mountain Valley MD Inc., the Company is engaged in implementing and licensing of its technologies to global pharmaceutical, vaccine and nutraceutical third parties. Its technology include Quicksome oral drug formulation and delivery technologies. The Company’s Quicksome desiccation technology utilizes advanced liposomes and other stabilizing molecules to encapsulate and formulate active ingredients into product formats that are consumed orally. The company is also developing other technologies, including Quicksol solubility formulation technology, and pending dose sparing adjuvant.
See Also
What is Mountain Valley MD Holdings Inc's Free Cash Flow?
Free Cash Flow
-2.3m
CAD
Based on the financial report for Dec 31, 2025, Mountain Valley MD Holdings Inc's Free Cash Flow amounts to -2.3m CAD.
What is Mountain Valley MD Holdings Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
9%
Over the last year, the Free Cash Flow growth was 45%. The average annual Free Cash Flow growth rates for Mountain Valley MD Holdings Inc have been 21% over the past three years , 9% over the past five years .
